Conversations on the science and business of Biotechnology with Andy Smith and Cormac Sheridan. To receive notifications when new episodes are published, email notifications@smithandsheridan.eu or follow us on LinkedIn.
Publishes | Weekly | Episodes | 27 | Founded | 4 months ago |
---|---|---|---|---|---|
Number of Listeners | Categories | BusinessNewsNews CommentaryInvesting |
Ophthalmology has long been a fruitful area for biotechnology innovation. In highly prevalent conditions associated with ageing, such as age-related macular degeneration, or with chronic disease, such as diabetic macular oedema, vascular endothelial ... more
For all the extraordinary progress we have seen in basic biological research and in the development of advanced therapies, allergy is an area that seems to be stuck and badly in need of innovation. For some, an allergy may be little worse than an irr... more
A couple of years ago, PROTACs were ubiquitous. Start-ups were devising increasingly clever ways of making them, while large pharma companies were queuing up to tap into their expertise and their development programs. Proteolysis-targeting chimeras, ... more
Over 10% of the world’s population – or 850 million people – are estimated to have kidney disease, and the problem is growing rapidly. The vast majority lives in low-income or low-and-middle-income countries, and, without access to primary healthcare... more
Human longevity is a precious thing. Some people receive a tragically short amount of it. Others who have it in abundance want even more of it – and a reasonable chunk of the biopharmaceutical industry has organised itself around the goal of deliveri... more
Therapeutic cancer vaccines have had a long and chequered history. The BCG (Bacillus Calmette-Guérin) vaccine, originally developed to protect against tuberculosis in the 1920s, was adopted back in the 1970s as treatment for bladder cancer. When deli... more
The flow of money is a constant preoccupation of the biotechnology sector, because without it nothing gets done. So, whether the markets are up or down, and whether investors are buying or selling is important, even if it is secondary to the actual b... more
The failure of Relyvrio in a post-approval phase 3 study in amyotrophic lateral sclerosis (ALS) means its days as a commercial drug are probably numbered. It initially gained approval in Canada in June 2022 (where it is, confusingly, known as Albrioz... more
Find out how many people listen to Smith & Sheridan on Biotech and see how many downloads it gets.
We scanned the web and collated all of the information that we could find in our comprehensive podcast database.
Listen to the audio and view podcast download numbers, contact information, listener demographics and more to help you make better decisions about which podcasts to sponsor or be a guest on.
Apple Podcasts | #218 |
Listeners, engagement and demographics and more for this podcast.
Listeners per Episode | Gender Skew | Engagement Score | |||
---|---|---|---|---|---|
Primary Location | Social Media Reach |
Rephonic provides a wide range of data for three million podcasts so you can understand how popular each one is. See how many people listen to Smith & Sheridan on Biotech and access YouTube viewership numbers, download stats, chart rankings, ratings and more.
Simply upgrade your account and use these figures to decide if the show is worth pitching as a guest or sponsor.
There are two ways to find viewership numbers for podcasts on YouTube. First, you can search for the show on the channel and if it has an account, scroll through the videos to see how many views it gets per episode.
Rephonic also pulls the total number of views for each podcast we find a YouTube account for. You can access these figures by upgrading your account and looking at a show's social media section.
Podcast streaming numbers or 'plays' are notoriously tricky to find. Fortunately, Rephonic provides estimated listener figures for Smith & Sheridan on Biotech and three million other podcasts in our database.
To check these stats and get a feel for the show's audience size, you'll need to upgrade your account.
To see how many followers or subscribers Smith & Sheridan on Biotech has, simply upgrade your account. You'll find a whole host of extra information to help you decide whether appearing as a sponsor or guest on this podcast is right for you or your business.
If it's not, use the search tool to find other podcasts with subscriber numbers that match what you're looking for.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. You can see some of this data for free. But you will need to upgrade your account to access premium data.
Smith & Sheridan on Biotech launched 4 months ago and published 27 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contact information for you.
Our systems scan a variety of public sources including the podcast's official website, RSS feed, and email databases to provide you with a trustworthy source of podcast contact information. We also have our own research team on-hand to manually find email addresses if you can't find exactly what you're looking for.
Rephonic pulls reviews for Smith & Sheridan on Biotech from multiple sources, including Apple Podcasts, Castbox, Podcast Addict and more.
View all the reviews in one place instead of visiting each platform individually and use this information to decide whether this podcast is worth pitching as a guest or sponsor.
You can view podcasts similar to Smith & Sheridan on Biotech by exploring Rephonic's 3D interactive graph. This tool uses the data displayed on the 'Listeners Also Subscribed To' section of Apple Podcasts to visualise connections between shows.